We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$22.1B
1-Year Est. Return
45.54%
This Fund
S&P 500
This Quarter
Est. Return
-3.28%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
–
AUM
$15.4B
AUM Growth
+$3.25B
(+27%)
Cap. Flow
+$3.84B
Cap. Flow
% of AUM
24.9%
Top 10 Holdings %
Top 10 Hldgs %
24.83%
Holding
2,819
New
321
Increased
2,347
Reduced
46
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$246M |
| 2 |
Microsoft
MSFT
|
+$216M |
| 3 |
Amazon
AMZN
|
+$130M |
| 4 |
Tesla
TSLA
|
+$79.6M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$73.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$49.3M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$11.7M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$11.6M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$5.56M |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$5.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.05% |
| 2 | Healthcare | 12.29% |
| 3 | Financials | 12.2% |
| 4 | Consumer Discretionary | 11.42% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZEN
1376
DELISTED
ZENDESK INC
ZEN
| $938K | 0.01% |
+7,801
| New | +$848K |
|
1377
Tanger
SKT
$4.42B
| $937K | 0.01% |
54,483
+19,491
| +56% | +$339K |
|
|
NVEE
1378
DELISTED
NV5 Global
NVEE
| $936K | 0.01% |
28,096
+9,552
| +52% | +$281K |
|
1379
Agios Pharmaceuticals
AGIO
$2B
| $933K | 0.01% |
32,047
+11,726
| +58% | +$358K |
|
1380
Virtus Investment Partners
VRTS
$1.12B
| $933K | 0.01% |
3,887
+1,388
| +56% | +$350K |
|
|
TGH
1381
DELISTED
Textainer Group Holdings limited
TGH
| $928K | 0.01% |
24,387
+8,848
| +57% | +$335K |
|
1382
Brinker International
EAT
$10.2B
| $928K | 0.01% |
24,327
+8,465
| +53% | +$317K |
|
|
VMW
1383
DELISTED
VMware, Inc
VMW
| $928K | 0.01% |
+8,151
| New | +$988K |
|
|
THS
1384
DELISTED
Treehouse Foods
THS
| $927K | 0.01% |
28,727
+9,923
| +53% | +$373K |
|
|
AVNS
1385
DELISTED
Avanos Medical
AVNS
| $926K | 0.01% |
27,642
+9,311
| +51% | +$300K |
|
1386
Magnite
MGNI
$3.53B
| $921K | 0.01% |
69,690
+24,725
| +55% | +$333K |
|
1387
Upbound Group
UPBD
$1.15B
| $919K | 0.01% |
36,471
+12,981
| +55% | +$469K |
|
1388
World Kinect Corp
WKC
$1.89B
| $917K | 0.01% |
33,929
+12,255
| +57% | +$340K |
|
1389
Horace Mann Educators
HMN
$2.09B
| $916K | 0.01% |
21,887
+8,283
| +61% | +$332K |
|
1390
B&G Foods
BGS
$299M
| $915K | 0.01% |
33,903
+12,233
| +56% | +$368K |
|
1391
Northern Oil and Gas
NOG
$2.61B
| $912K | 0.01% |
32,351
+14,853
| +85% | +$364K |
|
1392
Genworth Financial
GNW
$3.77B
| $910K | 0.01% |
240,785
+66,538
| +38% | +$267K |
|
|
VGR
1393
DELISTED
Vector Group Ltd.
VGR
| $910K | 0.01% |
75,551
+30,139
| +66% | +$335K |
|
|
SWTX
1394
DELISTED
SpringWorks Therapeutics
SWTX
| $908K | 0.01% |
16,081
+5,529
| +52% | +$316K |
|
1395
Zentalis Pharmaceuticals
ZNTL
$297M
| $907K | 0.01% |
19,665
+7,139
| +57% | +$385K |
|
1396
Under Armour Class C
UA
$2.25B
| $907K | 0.01% |
58,300
+10,784
| +23% | +$169K |
|
1397
Pathward Financial
CASH
$1.78B
| $906K | 0.01% |
16,505
+5,857
| +55% | +$333K |
|
1398
Pinterest
PINS
$13.2B
| $906K | 0.01% |
+36,823
| New | +$1.01M |
|
1399
ICF International
ICFI
$1.6B
| $901K | 0.01% |
9,571
+2,846
| +42% | +$267K |
|
1400
Supernus Pharmaceuticals
SUPN
$2.74B
| $901K | 0.01% |
27,869
+9,872
| +55% | +$303K |
|
Similar funds
BA
FAM
VARA
CHP
MIC
OAG
MetLife Investment Management's Q1 2022 Portfolio in Review
As of Q1 2022, MetLife Investment Management held 2,819 positions worth $15.4B, up 27% from $12.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
MetLife Investment Management deployed $3.84B of net new capital in Q1 2022, opening 321 new positions and adding to 2,347 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 519,200 shares worth $36M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $49.3M trimmed.
- MetLife Investment Management's largest Q1 2022 buy was iShares Russell 1000 Growth ETF: 519,200 shares worth $36M.
- MetLife Investment Management added most to Apple in Q1 2022, an estimated $246M increase.
- MetLife Investment Management's biggest Q1 2022 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $49.3M.
- MetLife Investment Management fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $11.7M.
- MetLife Investment Management's ten largest holdings make up 25% of its $15.4B portfolio in Q1 2022.
- MetLife Investment Management opened 321 new positions and closed 92 in Q1 2022.
- MetLife Investment Management's portfolio value rose 27% quarter-over-quarter to $15.4B.
Based on MetLife Investment Management's 13F filing for Q1 2022, filed 12 May 2022.